Latest News
3DR and Brainomix Partner to Advance Stroke Care in the US
Brainomix, a pioneer in stroke artificial intelligence (AI) imaging solutions, and 3DR Labs, the market leader in medical imaging post-processing services, announced a new strategic partnership to support acute stroke care in the US through the clinically validated and FDA-cleared Brainomix 360 Stroke.
Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
The University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated impact on thrombectomy and thrombolysis. Funding will also support clinical uptake of its breakthrough solution in lung fibrosis.
Brainomix Partners with Medtronic to Enhance Stroke Care
The collaboration between the leading stroke AI imaging partner and leading neurovascular device provider aims to enhance stroke care for patients by expanding access to life-changing treatments and improving patient outcomes.
New Data Presented at ISC Further Validates Treatment Impact of Brainomix 360
This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix's AI-powered software to expand access to life-changing stroke treatments across networks.
BBC News: Stroke Patient Says AI Diagnosis Was a 'Lifeline'
Shawn Theoff, a retired postman from Canterbury, suffered a stroke several years ago. He says that because of his quick AI-enhanced treatment with Brainomix 360 Stroke he was was out walking again within weeks.
NHS National Stroke Director: AI Is Helping to Speed Up the Diagnosis and Treatment of Stroke Patients
Dr David Hargroves highlights the clinical value that tools like Brainomix 360 Stroke are delivering for stroke patients.
Wales is leading the way to treat strokes with Artificial Intelligence
Nisha Patel is a 31-year-old new mother who recently suffered a stroke, but thanks to a new initiative that involved the deployment of Brainomix 360 Stroke across all hospitals in Wales, she was quickly diagnosed and promptly treated, enabling her to make a full recovery.
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
New data presented at Society of NeuroInterventional Surgery (SNIS) Annual Meeting in Colorado Spring highlights the cutting-edge, AI-enabled technology that has been developed for the Brainomix 360 Stroke platform
Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease
The project will evaluate the real-world impact of Brainomix's e-Lung imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis in the US
Brainomix Marks Stroke Awareness Month
We are inspired by stroke survivors like Jess Tierney, who suffered a stroke at age 29 and is now fully focused on her rehabilitation and channeling her energies towards raising awareness around stroke. Learn more about her story and her courageous spirit.
Brainomix Featured in The Economist Issue Focused on AI in Healthcare
The Economist cited Brainomix 360 Stroke as an example of an AI technology making an impact on healthcare, helping more stroke patients achieve an improved outcome.
Brainomix Hailed as Successful Example of Healthcare AI by NHS Transformation Directorate
Professor Erika Denton noted the impact Brainomix 360 Stroke can deliver by "significantly reducing the pathway of care for people presenting with stroke symptoms, with a profound impact in terms of morbidity and mortality from stroke.”
"Oxford Spinout Brainomix Is Revolutionising Stroke Care through AI"
The University of Oxford recently featured an article on Brainomix, highlighting the transformative progress we are achieving in stroke care. Our Oxford heritage continues to drive our focus on scientific excellence and world-class innovation.
Inside Precision Medicine Interviews Brainomix CEO
Our CEO Michalis Papadakis was recently interviewed by Helen Albert for her review of how AI is leading the way to more precise diagnostics and disease risk prediction.
NICE Endorses Brainomix 360 Stroke
New guidance from NICE, the globally respected health assessor, endorses the use of Brainomix 360 Stroke, acknowledging the impact that the AI-enabled software has demonstrated on stroke care, expanding patient access to life-changing treatments. Brainomix was one of only two companies granted this highly coveted endorsement.
Brainomix Awarded "Best Established MedTech" in the OBN Awards 2023.
Brainomix were recognized "for the clear evidence of their effectiveness and delivering on an area of significant unmet need."
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
Launched at the Society of Vascular and Interventional Neurology (SVIN) Conference in Miami, the Brainomix 360 platform is powered by best-in-class algorithms, delivering a unique technology for both specialist and non-specialist stroke centers that is poised to transform stroke care
Artificial Intelligence Helping Stroke Survivors at QEH
Stroke patients are getting the care they need faster thanks to new cutting-edge computer technology.
Brainomix Featured in PwC UK’s 'Life Sciences Future 50' Report
Brainomix are showcased as one of the 50 companies in PwC UK’s 'Life Sciences Future 50' report, which spotlights the world-class scientific and innovative contributions of the UK's life sciences sector.
Brainomix's e-Lung Software Featured in BBC News Coverage
e-Lung featured as part of the BBC coverage of the TIPAL study for lung fibrosis
Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics
e-Stroke Featured in The Guardian's "Future of Healthcare" Supplement
The article highlights the impact of e-Stroke on a network, enabling faster detection of stroke to allow more patients acces to thrombectomy, resulting in the prevention of stroke-related disability and death.
Brainomix Software Used in Post-Hoc Assessment of Acticor Biotech's ACTIMIS Study Results
The results generated by Brainomix's core lab analysis with its AI software reinforced glenzocimab's mode of action in stroke patients
Brainomix AI Technology Improves Access to Life-Changing Stroke Treatments
Sites with e-Stroke are delivering higher thrombectomy rates for stroke patients in a faster time, according to a recent report from the Oxford Academic Health Science Network
Brainomix Takes Two Top Prizes at Thames Valley Tech Awards
Brainomix was awarded Innovative Tech Company of the Year as well as Life Sciences & Health Tech Company of the Year.
Brainomix Showcased by Department of Health as Part of the New AI Fund
Brainomix's e-Stroke technology featured in the Department of Health's recent showcase of “most promising AI imaging and decision support tools” as part of the roll-out of the £21M AI Diagnostic Fund.
Brainomix Expands its UK Headquarters with New Facilities in Oxford
We've relocated to the landmark Seacourt Tower in Botley
Brainomix moves UK headquarters & opens in US
Oxford & Chicago facilities to accommodate growing team of specialists at company focused on treatments for stroke, lung fibrosis and cancer
Brainomix expands UK HQ with new Oxford facilities
Oxford-based AI-powered medtech solutions company Brainomix has announced its move to a new head office at the Seacourt Tower in Botley.
Brainomix expands U.K. headquarters
Artificial intelligence (AI) software developer Brainomix has expanded into new headquarters in Oxford, U.K.
Brainomix Joins CEO Roundtable on Cancer as Newest Member
The Oxford-based company is the first AI imaging company to join the organization
Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software
Our stroke AI solutions are now poised to take its transformative technology to US stroke centers
Stroke & AI: How the e-Stroke software is reducing door in door out time for stroke patients
National Consortium of Intelligent Medical Imaging video explaining how our e-Stroke software is reducing door in door out time for stroke patients
Brainomix Technology Integrated into New UK Atrial Fibrillation Study
The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients
UK atrial fibrillation research incorporates Brainomix
Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients
Brainomix AI used in UK atrial fibrillation study
This major study will look at how effective a wearable device and Brainomix AI software are in the detection of atrial fibrillation
Blackford and Brainomix Announce AI Partnership for Stroke Care
Strategic partnership increases access to advanced AI-assisted stroke care
AI-led system improving stroke treatment and outcomes
Brainomix e-Stroke system supporting cut in waiting times and reducing disability
Risk-averse NHS should stop more strokes with AI technology
Prof Kevin Moore advocates for the wider adoption of e-Stroke as a way of improving outcomes for stroke patients.
Rising stars: three fast-growing health and life sciences companies
Brainomix featured as part of a 'Rising Stars' piece on fast-growing UK health and life sciences companies, with an interview with CEO and Co-Founder Michalis Papadakis.
AI technology triples stroke recovery
Brainomix featured in The Times, highlighting the impact that the e-Stroke platform has had on stroke care in the NHS.
Artificial intelligence revolutionising NHS stroke care
Use of cutting-edge AI technology is associated with a tripling of the number of patients recovering and able to perform daily activities from 16% to 48%.
Brainomix announces new partnership with Pixyl to expand its offering with multiple sclerosis solution
Brainomix to distribute Pixyl.Neuro.MS Software as a Service (SaaS) solution exclusively in the UK and Ireland, the Nordics and key Eastern Europe markets
Brainomix, Visionable partner to boost care delivery for stroke patients
Visionable’s digital healthcare collaboration platform, used with Brainomix’s e-Stroke software, will allow more stroke patients to get appropriate treatment.
Visionable and Brainomix announce strategic partnership to tackle “bottlenecks” in time-sensitive stroke care pathway
Benefits of combining Visionable’s virtual platform with Brainomix’s e-Stroke imaging already demonstrated at Ipswich Hospital
UK digital health firms join together on stroke care platform
A partnership between two UK digital health companies – Brainomix and Visionable – aims to overcome stroke care bottlenecks.
Brainomix and Visionable announce AI partnership
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK.
Strategic partnership tackles bottlenecks in stroke pathway
Visionable and Brainomix use AI-powered solutions to address time-sensitive stroke care.
Brainomix Announces Collaboration with UK Government-Funded NCIMI to Evaluate AI-Powered Technology in Lung Cancer Care
Study to evaluate e-ACT for automated assessment of disease progression and treatment response for lung cancer
Brainomix and Bridge Biotherapeutics, Inc. Announce Partnership to Utilize Brainomix’ AI-Powered e-ILD Software for Automated Assessment of Idiopathic Pulmonary Fibrosis (IPF)
The partnership will focus on quantitative analysis of imaging data by Brainomix's e-ILD software within the Phase 2 Study of BBT-877 in IPF
Brainomix's AI Software to be Rolled Out Across Hungary’s Entire National Healthcare System to Improve Stroke Care
Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care.
Brainomix awarded tender to deploy AI stroke imaging across whole of Hungary
AI stroke imaging will be deployed across centers in Hungary after Brainomix was awarded a national tender.
Hungary will deploy Brainomix AI stroke software nationwide
Brainomix claims first national contract – from Hungary – for its AI platform for improved diagnosis and treatment of stroke.
Brainomix Expands Leadership Team with Appointment of Melissa Strange as Chief Financial Officer and Jérôme Galbrun as Chief Revenue Officer
New CFO and CRO appointed with overall resources more than doubling following last December’s £16M financing round
Brainomix Announces the Development of a Proprietary AI-Trained Predictive Biomarker for Idiopathic Pulmonary Fibrosis (IPF)
The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical trials
Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-Powered Radiomic Software for Automated Assessment of Solid Tumor Cancer
The collaboration will focus on the development of AI tools to improve the accuracy and standardization of tumor measurement in lung cancer trials
Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-Enabled Platform Beyond Stroke
The Series B investment will enable the Oxford-based company to expand its award-winning artificial intelligence (AI) portfolio into new indications and extend into new high-growth markets
Brainomix’s AI Stroke Software Goes Live Across Poland
Brainomix were awarded the first national tender in Europe to deploy its AI stroke software as part of the Polish Ministry of Health initiative to improve stroke care
BBC News Focuses on Brainomix Software
The segment showcases how Brainomix's e-Stroke software is helping the Royal Berkshire Hospital stroke team deliver best-in-class care.
Brainomix Featured in The New Statesman: "How AI Is Speeding Up Stroke Care"
Saving time in delivering thrombectomy services could be the difference between a good outcome and someone facing a life with a serious disability.
Brainomix's e-Stroke Featured in The Times
Article highlights the value of e-Stroke in helping physicians identify stroke and optimize treatment
Brainomix Announces New Partnership with Stryker Neurovascular to Expand Access to Life-Saving Stroke Treatments
The partnership will enable both companies to work towards improving care across stroke networks
Brainomix Announced as Founder Member of Open Source Imaging Consortium (OSIC)
Joins renowned global organization connecting academia, industry and philanthropy in the fight against lung disease
Brainomix Joins the Endeavor Scale-Up Program
Joins global network of fast-growing, innovative companies founded by Greek entrepreneurs.
Brainomix Featured in Financial Times
Announcement of New Chairperson and Expanded Board Featured in FT
Brainomix Announces Appointment of New Chairperson and Expanded Board
The Oxford-based company at the forefront of medical AI imaging welcomes new Board members with pharmaceutical and imaging expertise
AI Software Developers Win Big in U.K. Initiative
Brainomix awarded NHSX grant for AI software
University Hospital Milton Keynes adopts AI
University Hospital Milton Keynes NHS FT has adopted AI technology from Brainomix into its Stroke Practice
Brainomix Awarded Prestigious AI Grant to Demonstrate Impact in NHS
Company selected to participate in groundbreaking NHS AI initiative
e-Stroke Suite Featured in Royal College of Physicians' Podcast
Dr Kiruba Nagaratnam discusses changes to the thrombectomy pathway and assesment during COVID-19
Brainomix Software Featured in Sky News Segment
e-Stroke Suite was showcased as part of a Sky News segment on how AI solutions are helping stroke teams
AI Technology Developed in Oxford Speeds Up Stroke Care and Reduces Cost
Clinicians are making swift, accurate decisions around stroke care thanks to AI-enabled imaging software
Brainomix AI Software Featured in The Daily Mail
Article focused on the role of AI solutions in healthcare
Royal Berkshire Hospital Becomes The First To Use AI Software To Diagnose Strokes
e-Stroke Suite has been deployed at Royal Berks
Slovakian News Showcases Brainomix Software as Part of Regional Stroke Network Deployment
e-Stroke Suite is being rolled out across one of the largest stroke networks in Slovakia
Brainomix Included in Prestigious Group of "Global Digital Health 100" Companies
Awards recognize companies with greatest potential to change the way healthcare is delivered
Six Industry Experts Share their Vision for Healthcare IT in 2020
Brainomix CEO and Co-Founder, Dr Michalis Papadakis, discusses the role of AI in healthcare
UK Clinical Network Launches Pioneering AI Stroke Project
The collaboration will enable Trusts in the network to introduce intelligent AI algorithms into existing radiology workflows
Brainomix AI software improves stroke treatment rates at Budapest University Hospital
Results showed that treatment rates for stroke patients improved and treatment times were reduced following the installation of Brainomix’s e-Stroke Suite
Brainomix Featured in BBC Technology Segment Focused on AI in Healthcare
Brainomix were recently featured in a BBC News Technology segment focused on AI in healthcare
Brainomix Listed as Finalist for “Best New Radiology Software” for Its e-CTA Stroke Imaging Solution
Awards recognize excellence in European Radiology
Angels Initiative Wins Prestigious 2018 EFPIA Health Collaboration Award for Improving Stroke Care
Brainomix is the sole imaging partner for the community of more than 1,000 hospitals enrolled in the Angels Initiative
Brainomix Partners with Oxford University in UK Government-Funded £17.5 Million Artificial Intelligence Programme
Stroke imaging software, e-Stroke Suite, to demonstrate life-saving impact of AI-based technologies
Brainomix Secures £7m ($9.8m) Investment to Tackle Stroke with AI
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims
Brainomix Featured in Oxford Mail
" Summertown firm's Brainy idea will help stroke victims across Europe..."
Brainomix Announces Partnership with Boehringer Ingelheim's Angels Initiative
Partnership will enable both companies to help improve stroke care across the region
Brainomix Completes a £1.5 Million Investment Round
Funding will enable Brainomix to further commercialize its proprietary software
Brainomix receives funding to develop clinical decision-making software for stroke patients
Brainomix Limited, a developer of automated medical imaging software for neurological
Brainomix launches revolutionary e-ASPECTS software designed to improve outcomes for stroke patients
Breakthrough technology automates analysis of CT brain scans to support doctors in
Our Partners
